Alessandro Serretti
#93,972
Most Influential Person Now
Researcher
Alessandro Serretti's AcademicInfluence.com Rankings
Alessandro Serrettiphilosophy Degrees
Philosophy
#3521
World Rank
#5675
Historical Rank
Logic
#1207
World Rank
#1898
Historical Rank
Download Badge
Philosophy Biology
Alessandro Serretti's Degrees
- PhD Psychiatry University of Bologna
- Doctorate Medicine University of Bologna
Why Is Alessandro Serretti Influential?
(Suggest an Edit or Addition)Alessandro Serretti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. (2009) (1544)
- Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. (2011) (1097)
- Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder (2017) (998)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- A systematic review of neurobiological and clinical features of mindfulness meditations (2009) (676)
- Mindfulness based cognitive therapy for psychiatric disorders: A systematic review and meta-analysis (2011) (612)
- The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients (2007) (516)
- Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis (2009) (457)
- Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder (2010) (419)
- Antidepressants and body weight: a comprehensive review and meta-analysis. (2010) (395)
- Mindfulness: top-down or bottom-up emotion regulation strategy? (2013) (384)
- Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. (2007) (373)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression (2015) (340)
- Mindfulness-based interventions for chronic pain: a systematic review of the evidence. (2011) (331)
- Are Mindfulness-Based Interventions Effective for Substance Use Disorders? A Systematic Review of the Evidence (2014) (322)
- Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression (2003) (311)
- Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy (2012) (291)
- Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression (2017) (259)
- Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism (2003) (250)
- Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) (240)
- Serotonin transporter gene variants and behavior: a comprehensive review. (2006) (218)
- Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression (2001) (210)
- The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions (2008) (208)
- Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression (2007) (192)
- A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression (2004) (190)
- Depressive symptomatology is influenced by chronotypes. (2009) (190)
- Personality and attempted suicide. Analysis of anger, aggression and impulsivity. (2009) (189)
- Pharmacogenetics in major depression: A comprehensive meta-analysis (2013) (179)
- Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β −50 T/C SNP (2005) (177)
- Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study (2005) (176)
- Pharmacogenetics of antidepressant response. (2011) (174)
- A single nucleotide polymorphism in glycogen synthase kinase 3-β promoter gene influences onset of illness in patients affected by bipolar disorder (2004) (170)
- Social brain, social dysfunction and social withdrawal (2019) (167)
- Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder (2000) (165)
- Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity (2001) (163)
- Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. (1999) (163)
- HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. (2007) (160)
- Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism (2005) (160)
- Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. (2007) (154)
- Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. (1998) (152)
- A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics (2011) (149)
- Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features (2012) (148)
- ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder (2008) (147)
- Gene environment interaction studies in depression and suicidal behavior: An update (2013) (143)
- Clozapine resistance: Augmentation strategies (2012) (139)
- Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. (2011) (134)
- The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. (2004) (130)
- Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review. (2015) (129)
- Serotonergic genes and suicide: A systematic review (2013) (122)
- Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review (2014) (121)
- Possible association between –G308A tumour necrosis factor-&agr; gene polymorphism and major depressive disorder in the Korean population (2003) (119)
- Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. (2000) (115)
- European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings (2012) (114)
- New antipsychotics and schizophrenia: a review on efficacy and side effects. (2004) (114)
- Tryptophan hydroxylase gene associated with paroxetine antidepressant activity (2001) (113)
- The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments (2005) (109)
- Weight gain in antipsychotic-naive patients: a review and meta-analysis (2009) (109)
- Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. (2006) (107)
- Serotonin transporter gene associated with lithium prophylaxis in mood disorders (2001) (107)
- Pharmacogenetics of Antidepressants (2010) (102)
- Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders (1999) (101)
- Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients (2012) (100)
- Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. (2002) (100)
- Profiles of "manic" symptoms in bipolar I, bipolar II and major depressive disorders. (2005) (99)
- The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls (2018) (99)
- Social adjustment and self-esteem of bipolar patients: a multicentric study. (2004) (97)
- Occurrence of Cognitive Impairment and Dementia after the Age of 60: A Population-Based Study from Northern Italy (2005) (97)
- The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder (2013) (95)
- Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder (2009) (94)
- Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles. (2008) (94)
- Serotonin transporter gene (5-HTTLPR) and major psychoses (2002) (94)
- Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression (2011) (94)
- Genetics of Alzheimer's disease. A rapidly evolving field. (2007) (93)
- Psychological mechanisms of mindfulness-based interventions: what do we know? (2014) (93)
- Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene (2003) (92)
- Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study (2004) (92)
- The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes (2013) (92)
- The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis (2018) (89)
- Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. (2009) (89)
- HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers (2007) (88)
- The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. (2011) (86)
- Temperament and Character in Mood Disorders: Influence of DRD4, SERTPR, TPH and MAO-A Polymorphisms (2006) (86)
- Aripiprazole in the Treatment of Depressive and Anxiety Disorders (2008) (85)
- Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. (1999) (84)
- The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials (2008) (83)
- The 5-HTTLPR polymorphism and posttraumatic stress disorder: a meta-analysis. (2013) (83)
- SSRIs antidepressant activity is influenced by Gβ3 variants (2003) (82)
- Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research (2013) (81)
- Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. (2013) (80)
- Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients (2009) (80)
- Gene–environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms (2003) (79)
- Temperament and character of suicide attempters. (2008) (79)
- Pharmacogenetic studies in depression: a proposal for methodologic guidelines (2008) (78)
- Pharmacogenetics in the treatment of depression: pharmacodynamic studies (2005) (78)
- Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine. (1994) (77)
- Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice (2019) (75)
- The pharmacogenomics of selective serotonin reuptake inhibitors (2004) (75)
- The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression (2015) (74)
- Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. (2009) (74)
- Dimensions of major psychoses: a confirmatory factor analysis of six competing models (2004) (73)
- Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study (2001) (73)
- Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response (2017) (73)
- Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study (2018) (73)
- Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample. (2017) (72)
- Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications (2015) (71)
- Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders (2004) (71)
- Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. (2002) (69)
- Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism (2011) (69)
- The influence of childhood trauma on the onset and repetition of suicidal behavior: an investigation in a high risk sample of male prisoners. (2011) (68)
- Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. (2016) (68)
- Genetic modulation of personality traits: a systematic review of the literature (2014) (67)
- DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. (2001) (67)
- Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors (2020) (66)
- Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder. (2015) (65)
- Mindfulness-based cognitive therapy versus psycho-education for patients with major depression who did not achieve remission following antidepressant treatment: a preliminary analysis. (2012) (65)
- A New Prediction Model for Evaluating Treatment-Resistant Depression. (2017) (64)
- Identification of symptomatologic patterns common to major psychoses: proposal for a phenotype definition. (1996) (64)
- Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone (2019) (64)
- Evidence for an association between the dopamine D3 receptor gene DRD3 and schizophrenia. (1997) (64)
- How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes (2007) (64)
- Focus on HTR2C: A possible suggestion for genetic studies of complex disorders (2009) (63)
- A quantitative approach to neuropsychiatry: The why and the how (2017) (63)
- The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes (2011) (63)
- Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. (2002) (62)
- Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials. (2014) (62)
- Pharmacogenetics in affective disorders. (2002) (62)
- Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses (2000) (62)
- Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study. (2017) (62)
- Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders. (2000) (61)
- Mindfulness-based cognitive therapy vs. psycho-education for patients with major depression who did not achieve remission following antidepressant treatment (2015) (61)
- NOS‐I and ‐III gene variants are differentially associated with facets of suicidal behavior and aggression‐related traits (2008) (60)
- Symptomatologic analysis of psychotic and non-psychotic depression. (1999) (60)
- Excess of allele1 for α3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study (2002) (59)
- Dopamine receptor D2 and D4 genes, GABAA alpha-1 subunit gene and response to lithium prophylaxis in mood disorders (1999) (59)
- Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. (1998) (59)
- 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. (2008) (59)
- Influence of BDNF Variants on Diagnosis and Response to Treatment in Patients with Major Depression, Bipolar Disorder and Schizophrenia (2011) (58)
- Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants (2009) (58)
- Serotonin transporter gene and adverse life events in adult ADHD (2008) (58)
- Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. (2002) (58)
- Tryptophan hydroxylase gene and major psychoses (2001) (57)
- 5‐HT1A polymorphism and self‐transcendence in mood disorders (2005) (57)
- Antidepressants in healthy subjects: What are the psychotropic/psychological effects? (2010) (57)
- Acute antipyschotic efficacy and side effects in schizophrenia: Association with serotonin transporter promoter genotypes (2008) (57)
- Depressive syndrome in major psychoses: a study on 1351 subjects (2004) (57)
- The 5-HT2C receptor as a target for mood disorders (2004) (56)
- Neural network analysis in pharmacogenetics of mood disorders (2004) (56)
- Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. (2019) (56)
- Mode of inheritance in mood disorder families according to fluvoxamine response (1998) (55)
- From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant Treatment (2014) (55)
- Clinical and demographic features of mood disorder subtypes (2002) (55)
- Major psychoses symptomatology: factor analysis of 2241 psychotic subjects (2001) (55)
- From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes (2004) (55)
- Sexual Side Effects of Pharmacological Treatment of Psychiatric Diseases (2011) (54)
- A protective genetic variant for adverse environments? The role of childhood traumas and serotonin transporter gene on resilience and depressive severity in a high-risk population (2011) (54)
- Delineating psychopathologic clusters within dysthymia: a study of 512 out-patients without major depression. (1999) (54)
- Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment. (2004) (54)
- The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants (2018) (53)
- Shared genetics among major psychiatric disorders (2013) (53)
- Genetics of Late-Onset Alzheimer's Disease: Update from the Alzgene Database and Analysis of Shared Pathways (2011) (53)
- Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis (2016) (52)
- SSRIs antidepressant activity is influenced by G beta 3 variants. (2003) (52)
- Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study (2009) (52)
- Mechanisms of antidepressant action: An integrated dopaminergic perspective (2011) (51)
- Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders (2004) (51)
- Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls. (2009) (51)
- Serotonin transporter gene influences the time course of improvement of “core” depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders (2007) (51)
- Cognitive markers of psychotic unipolar depression: a meta-analytic study. (2015) (51)
- Safety and Tolerability of Lamotrigine: Results From 12 Placebo-Controlled Clinical Trials and Clinical Implications (2011) (50)
- 5-HTTLPR and gender differences in affective disorders: A systematic review. (2016) (50)
- Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics (2017) (50)
- Social adjustment and self-esteem in remitted patients with mood disorders (1999) (50)
- Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long‐term antipsychotic treatment (2007) (50)
- Effects of fluoxetine at antidepressant doses on short‐term outcome of detoxified alcoholics (1996) (50)
- Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants (2006) (50)
- Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients. (2009) (49)
- Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment (2013) (48)
- Newer antidepressants and panic disorder: a meta-analysis (2013) (48)
- Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder (2004) (47)
- The use of the defence style questionnaire in major depressive and panic disorders: a comprehensive meta-analysis. (2010) (47)
- Association between GSK-3β -50T/C polymorphism and personality and psychotic symptoms in mood disorders (2008) (47)
- Quetiapine XR: Current status for the treatment of major depressive disorder (2010) (47)
- Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts (2020) (47)
- Factor analysis of delusional disorder symptomatology. (1999) (47)
- A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder. (2000) (47)
- No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors (2001) (47)
- Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study (2011) (46)
- A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. (2011) (46)
- Genetic modulation of borderline personality disorder: systematic review and meta-analysis. (2013) (46)
- Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. (2001) (46)
- A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders (2011) (46)
- Clinical, psychological and environmental predictors of prospective suicide events in patients with Bipolar Disorder. (2013) (45)
- European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors (1998) (45)
- Functional neural correlates of mindfulness meditations in comparison with psychotherapy, pharmacotherapy and placebo effect. Is there a link? (2010) (45)
- Interaction between SERTPR and stressful life events on response to antidepressant treatment (2007) (44)
- Pharmacogenetics of antidepressant response: An update (2009) (44)
- Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression. (2015) (44)
- Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders. (1998) (44)
- Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders (2009) (44)
- Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population (2004) (44)
- Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis. (2015) (44)
- Genetics of resilience: Implications from genome‐wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression (2019) (43)
- Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study (2016) (43)
- Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: An exploratory analysis (2006) (43)
- Components of self-esteem in affective patients and non-psychiatric controls. (2005) (43)
- Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants. (2002) (43)
- Sertraline Versus Fluvoxamine in the Treatment of Elderly Patients With Major Depression: A Double-blind, Randomized Trial (2005) (43)
- Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD) (2018) (42)
- The socio-economical burden of schizophrenia: A simulation of cost-offset of early intervention program in Italy (2009) (42)
- The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder — A European Multicenter Study (2012) (42)
- 5-HT2A SNPs and the Temperament and Character Inventory (2007) (42)
- Quetiapine for bipolar depression: a systematic review and meta-analysis (2012) (42)
- Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia (2011) (42)
- Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression (2006) (42)
- MDR1 gene polymorphisms and response to acute risperidone treatment (2010) (41)
- Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia (2008) (41)
- A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression. (2016) (41)
- Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia (1998) (41)
- MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls (2013) (41)
- Insomnia and Somnolence Associated With Second-Generation Antidepressants During the Treatment of Major Depression: A Meta-Analysis (2015) (40)
- HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study (2007) (40)
- Heat-shock protein-70 genes and response to antidepressants in major depression (2007) (40)
- Genetic variants of dopamine receptor D4 and psychopathology. (1998) (39)
- Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population (2004) (39)
- Enrichment pathway analysis. The inflammatory genetic background in Bipolar Disorder. (2015) (39)
- Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre (2006) (39)
- 3111T/C CLOCK GENE POLYMORPHISM IS NOT ASSOCIATED WITH SLEEP DISTURBANCES IN UNTREATED DEPRESSED PATIENTS (2010) (38)
- Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD) (2018) (38)
- BanI Polymorphism of the Cytosolic Phospholipase A2 Gene and Mood Disorders in the Korean Population (2004) (38)
- Pooling pharmacogenetic studies on the serotonin transporter: A mega-analysis (2006) (38)
- Neuroticism, social network, stressful life events: Association with mood disorders, depressive symptoms and suicidal ideation in a community sample of women (2015) (38)
- Effect of 5‐haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder (2007) (37)
- Depression across mood disorders: review and analysis in a clinical sample. (2012) (37)
- Catechol-O-methyltransferase gene variants in mood disorders in the Italian population. (2006) (37)
- Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients (2013) (37)
- Clinical and demographic features of psychotic and nonpsychotic depression. (1999) (37)
- Factor analysis of mania. (1999) (37)
- Case–control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics (2012) (36)
- Clinical and genetic factors associated with suicide in mood disorder patients (2016) (36)
- Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population (2004) (36)
- TPH1, MAOA, Serotonin Receptor 2A and 2C Genes in Citalopram Response: Possible Effect in Melancholic and Psychotic Depression (2012) (35)
- Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries (2012) (35)
- The influence of the serotonin transporter gene 5-HTTLPR polymorphism on suicidal behaviors: a meta-analysis (2019) (35)
- HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory (2009) (35)
- Vitamin B12 levels in Alzheimer's disease: association with clinical features and cytokine production. (2010) (35)
- Multicentre Italian family‐based association study on tyrosine hydroxylase, catechol‐O‐methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders (2003) (35)
- Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer’s disease in two independent European samples (2013) (35)
- Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials (2018) (35)
- Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode. (2013) (34)
- Progress and prospects in pharmacogenetics of antidepressant drugs (2016) (34)
- Analysis of depressive symptomatology in mood disorders (1998) (34)
- Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders (1998) (33)
- COMT and age at onset in mood disorders: A replication and extension study (2011) (33)
- Serotonin transporter gene is not associated with symptomatology of schizophrenia (1999) (33)
- A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder (2018) (33)
- HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis (2015) (33)
- PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway (2014) (33)
- Pharmacogenetics in Psychiatry: An Update on Clinical Usability (2020) (33)
- Impact of clinical variables on illness time course in mood disorders (2000) (33)
- Escitalopram plasma levels and antidepressant response (2017) (33)
- Family history of a mood disorder indicates a more severe bipolar disorder. (2014) (32)
- Linkage of mood disorders with D2, D3 and TH genes: a multicenter study. (2000) (32)
- White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress (2018) (32)
- Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia (2005) (32)
- The role of serotonergic genes and environmental stress on the development of depressive symptoms and neuroticism. (2012) (32)
- Genetics of long-term treatment outcome in bipolar disorder (2016) (32)
- Influence of postpartum onset on the course of mood disorders (2006) (31)
- Schizophrenia-Like Symptoms in Narcolepsy Type 1: Shared and Distinctive Clinical Characteristics (2015) (31)
- Clinical prediction of antidepressant response in mood disorders: Linear multivariate vs. neural network models (2007) (31)
- Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients (2008) (31)
- Clinical correlates of augmentation/combination treatment strategies in major depressive disorder (2018) (31)
- Trait-aggressiveness and impulsivity: Role of psychological resilience and childhood trauma in a sample of male prisoners (2014) (31)
- No Association of TPH1 218A/C Polymorphism with Treatment Response and Intolerance to SSRIs in Japanese Patients with Major Depression (2008) (30)
- Dopamine receptor D4 gene is not associated with major psychoses. (1999) (30)
- Tumor necrosis factor‐α gene polymorphism at position −308 and schizophrenia in the Korean population (2003) (30)
- Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: A principal component analysis of lifetime pharmacological and biophysic treatment options (2013) (30)
- Genetics of serotonin receptors and depression: state of the art. (2013) (30)
- Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder (2003) (30)
- Genes involved in Alzheimer's disease, a survey of possible candidates. (2005) (30)
- Further evidence of MAO‐A gene variants associated with bipolar disorder (2007) (30)
- Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder (2013) (29)
- Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples (2018) (29)
- Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder (2012) (29)
- Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D (2013) (29)
- Correlation of a set of gene variants, life events and personality features on adult ADHD severity. (2010) (29)
- Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up. (2004) (28)
- Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines (2010) (28)
- Clinical factors related to schizophrenia relapse (2016) (28)
- A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping (2019) (28)
- Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. (2011) (28)
- The 3111T/C Polymorphism Interacts With Stressful Life Events to Influence Patterns of Sleep in Females (2012) (28)
- Neuronal cell adhesion genes and antidepressant response in three independent samples (2015) (28)
- APOE epsilon‐4 allele and cytokine production in Alzheimer's disease (2010) (28)
- AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment (2013) (28)
- Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. (2005) (28)
- The Impact of Heat Shock Protein 70 Gene Variations on Clinical Presentation and Outcome in Schizophrenic Inpatients (2009) (28)
- Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis (2016) (28)
- Catechol-o-methyltransferase and Alzheimer's disease: a review of biological and genetic findings. (2012) (28)
- Bipolar II disorder as a risk factor for postpartum depression. (2016) (28)
- Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression. (2019) (28)
- Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder (2013) (27)
- 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients (2009) (27)
- A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial (2018) (27)
- Serum Testosterone Concentration in Combat-Related Chronic Posttraumatic Stress Disorder (2012) (27)
- Predictors of switch from depression to mania in bipolar disorder. (2015) (27)
- The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives (2018) (27)
- Patterns of symptom improvement during antidepressant treatment of delusional depression (2000) (27)
- Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance (2018) (26)
- Genetic variability in CYP2E1 and catalase gene among currently and formerly alcohol-dependent male subjects. (2015) (26)
- Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder (2020) (26)
- The serotonin transporter gene and effectiveness of SSRIs (2008) (26)
- Role of 108 schizophrenia‐associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder (2017) (26)
- Clinical features and drug induced side effects in early versus late antidepressant responders. (2013) (26)
- The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study. (2014) (26)
- Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). (2009) (26)
- Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials (2017) (25)
- Temperament and character influence on depression treatment outcome. (2019) (25)
- Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation (1999) (25)
- Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population (2003) (25)
- Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression. (2018) (25)
- Dopamine transporter haplotype and attention-deficit hyperactivity disorder (2005) (25)
- Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects (2009) (25)
- CACNA1C gene and schizophrenia: a case–control and pharmacogenetic study (2015) (25)
- Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment. (2010) (25)
- Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study (2003) (25)
- Comparison of Response to Fluvoxamine in Nondemented Elderly Compared to Younger Patients Affected by Major Depression (2003) (25)
- Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy (2007) (25)
- Case–control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder (2012) (24)
- Rapid cycling mood disorder: clinical and demographic features. (2002) (24)
- Incomplete Coverage of Candidate Genes: A Poorly Considered Bias (2007) (24)
- Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome. (2012) (24)
- Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. (2000) (24)
- Thyroid hormones affect recovery from depression during antidepressant treatment (2009) (24)
- Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors (2009) (24)
- Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis (2021) (24)
- Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway (2016) (24)
- Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer's disease in two Independent European samples. (2009) (24)
- Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression (2012) (23)
- Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome (2012) (23)
- Potential role of membrane-bound COMT gene polymorphisms in female depression vulnerability. (2013) (23)
- Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment (2014) (23)
- The CLOCK Gene and Mood Disorders: A Case-Control Study and Meta-analysis (2011) (23)
- T3111C CLOCK SINGLE NUCLEOTIDE POLYMORPHISM AND MOOD DISORDERS: A META-ANALYSIS (2010) (23)
- Dysbindin gene (DTNBP1) and schizophrenia in Korean population (2009) (23)
- Serotonin transporter gene not associated with psychotic symptomatology of mood disorders (1999) (23)
- Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison (2017) (23)
- Serotonin-2C and serotonin-1A receptor genes are not associated with psychotic symptomatology of mood disorders. (2000) (22)
- A neural network model for combining clinical predictors of antidepressant response in mood disorders. (2007) (22)
- Interaction between the Tryptophan Hydroxylase Gene and the Serotonin Transporter Gene in Schizophrenia but Not in Bipolar or Unipolar Affective Disorders (2005) (22)
- Relating constructs of attention and working memory to social withdrawal in Alzheimer’s disease and schizophrenia: issues regarding paradigm selection (2019) (22)
- Genome-wide association study identifies 30 loci associated with bipolar disorder (2019) (22)
- Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression (2003) (22)
- Serious suicidal behaviors: Socio-demographic and clinical features in a multinational, multicenter sample (2014) (22)
- Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders (1998) (22)
- Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression (2012) (22)
- New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. (2020) (22)
- Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior (2008) (21)
- Self-Harm in Prisoners (2011) (21)
- Tachykinin receptor 1 variants associated with aggression in suicidal behavior (2007) (21)
- Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder (2014) (21)
- Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: The role of clinical, psychosocial and genetic variables (2006) (21)
- The genetics of antipsychotic induced tremors: A genome‐wide pathway analysis on the STEP‐BD SCP sample (2011) (21)
- Effect of reboxetine augmentation in SSRI resistant patients (2000) (21)
- Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples (2013) (21)
- Antidepressant response in the elderly (2007) (21)
- Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case–control study (2003) (21)
- Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol (2010) (21)
- The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment – a European multicentre study (2016) (21)
- Polymorphism of the Serotonin Transporter Gene and Symptomatic Dimensions of Schizophrenia in the Korean Population (2003) (21)
- Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression (2019) (20)
- A molecular pathway analysis informs the genetic background at risk for schizophrenia (2015) (20)
- CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. (2015) (20)
- The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial (2016) (20)
- No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression (2013) (20)
- HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia (2015) (20)
- Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression (2014) (20)
- No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. (1999) (20)
- Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder (2013) (20)
- Neuro-imaging of mindfulness meditations: implications for clinical practice (2011) (19)
- Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials (2016) (19)
- GABAA alpha-1 subunit gene not associated with depressive symptomatology in mood disorders. (1998) (19)
- Melancholic features and response to lithium prophylaxis in mood disorders (2000) (19)
- Investigation of an epistastic effect between a set of TAAR6 and HSP‐70 genes variations and major mood disorders (2010) (19)
- Identifying the Common Genetic Basis of Antidepressant Response (2021) (19)
- TAAR6 variations possibly associated with antidepressant response and suicidal behavior (2010) (19)
- Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future (2020) (19)
- Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing (2021) (19)
- Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder (2008) (19)
- Antipsychotic Response in the First Week Predicts Later Efficacy (2012) (18)
- Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders (2021) (18)
- Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance (2018) (18)
- Interleukin‐10 gene promoter polymorphism is not associated with schizophrenia in the Korean population (2003) (18)
- Paroxetine for the treatment of depression: a critical update (2012) (18)
- Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study. (1999) (18)
- The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder (2013) (18)
- Dopamine D3 receptor gene not associated with symptomatology of major psychoses. (1999) (17)
- Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial (2016) (17)
- The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study (2017) (17)
- No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors. (2001) (17)
- Understanding the pharmacogenetics of selective serotonin reuptake inhibitors (2014) (17)
- Interaction analysis between 5-HTTLPR and TNFA −238/−308 polymorphisms in schizophrenia (2006) (17)
- Monocyte chemoattractant protein-1 promoter –2518 polymorphism and schizophrenia in the Korean population (2004) (17)
- Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples (2019) (17)
- Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: Depression vs. sub-threshold mixed state (2011) (17)
- Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol (2013) (17)
- Pharmacogenetics and Depression: A Critical Perspective (2019) (17)
- Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease (2020) (17)
- Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature (2018) (17)
- Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study (2010) (17)
- The CLOCK gene and mood disorders: a case-control study and meta-analysis. (2011) (17)
- T31 Genes Involved In Neurodevelopment, Neuroplasticity And Bipolar Disorder: Cacna1c, Chrna1 And MAPK1 (2017) (17)
- Duloxetine plasma level and antidepressant response (2019) (16)
- Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study (2019) (16)
- No evidence for interaction between 5-HT2A receptor and serotonin transporter genes in schizophrenia (2005) (16)
- TAAR 6 and HSP-70 variations associated with bipolar disorder (2009) (16)
- DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients (2008) (16)
- ANTIPSYCHOTICS AND SEXUAL DYSFUNCTION: EPIDEMIOLOGY, MECHANISMS AND MANAGEMENT (2013) (16)
- Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs (2015) (16)
- TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study (2008) (16)
- Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment (2020) (16)
- Is cognitive behavioural therapy an effective complement to antidepressants in adolescents? A meta-analysis (2011) (16)
- TNFB polymorphism may be associated with schizophrenia in the Korean population (2003) (16)
- Estrogen receptor gene 1 variants are not associated with suicidal behavior (2008) (16)
- Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies (2020) (16)
- Effects of antipsychotic drugs on insight in schizophrenia (2014) (15)
- What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram (2015) (15)
- Personalized and precision medicine as informants for treatment management of bipolar disorder. (2019) (15)
- Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia (2012) (15)
- Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study (2020) (15)
- Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7 (2020) (15)
- Depression and Social Phobia Secondary to Alcohol Dependence (2008) (15)
- Two new rare variants in the circadian “clock” gene may influence sleep pattern (2005) (15)
- Predicting Response to Lithium in Mood Disorders (2003) (15)
- Lithium long-term treatment in mood disorders: clinical and genetic predictors. (2002) (15)
- DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy. (2014) (15)
- Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance (2017) (15)
- Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance (2010) (15)
- Association of SORL1 alleles with late-onset Alzheimer's disease. findings from the GIGAS_LOAD study and mega-analysis. (2012) (15)
- Pharmacogenetics in Psychiatry. (2018) (15)
- Ethical problems in pharmacogenetic studies of psychiatric disorders (2006) (14)
- Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample (2018) (14)
- Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes (2015) (14)
- Dopamine D2 receptor gene not associated with symptomatology of mood disorders. (1999) (14)
- Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression (2021) (14)
- Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients. (2013) (14)
- Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT. (2017) (14)
- The Influence of AHI1 Variants on the Diagnosis and Treatment Outcome in Schizophrenia (2015) (14)
- Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment (2009) (14)
- Precision psychiatry in clinical practice (2020) (14)
- Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials. (2011) (14)
- Pharmacogenetics of Lithium Long-Term Treatment: Focus on Initiation and Adaptation Mechanisms (2010) (14)
- Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample (2015) (14)
- Alcohol Dependence and Genetic Variability in the Serotonin Pathway among Currently and Formerly Alcohol-Dependent Males (2015) (14)
- The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder (2017) (14)
- Association between the estrogen receptor TA polymorphism and Harm avoidance (2009) (13)
- VNTR Polymorphism of Tyrosine Hydroxylase Gene and Schizophrenia in the Korean Population (2003) (13)
- No interaction between serotonin transporter gene and dopamine receptor D4 gene in symptomatology of major psychoses. (1999) (13)
- Association between Sirtuin 1 Gene rs10997870 Polymorphism and Suicide Behaviors in Bipolar Disorder (2016) (13)
- Predictors of Early Worsening after Switch to Aripiprazole (2010) (13)
- Sociodemographic Features Predict Antidepressant Trajectories of Response in Diverse Antidepressant Pharmacotreatment Environments: A Comparison Between the STAR*D Study and an Independent Trial (2011) (13)
- How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach (2020) (13)
- Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases (2007) (13)
- HSP70 polymorphisms in first psychotic episode drug-naïve schizophrenic patients. (2014) (13)
- Seasonal variations of lithium plasma levels (2002) (13)
- The Impact of Adverse Life Events on Clinical Features and Interaction with Gene Variants in Mood Disorder Patients (2013) (12)
- NCAM1, TACR1 and NOS Genes and Temperament: A Study on Suicide Attempters and Controls (2011) (12)
- Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study (2018) (12)
- No Association of a Set of Candidate Genes on Haloperidol Side Effects (2012) (12)
- Predominant polarity in bipolar disorder patients: The COPE bipolar sample. (2019) (12)
- No association between serotonin-2A receptor gene polymorphism and psychotic symptomatology of mood disorders (1999) (12)
- The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades. (2016) (12)
- Predicting response to lithium in mood disorders: role of genetic polymorphisms. (2003) (12)
- Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study (2020) (12)
- Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder (2014) (11)
- Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trial (2013) (11)
- Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects (2005) (11)
- Influence of differentially expressed genes from suicide post-mortem study on personality traits as endophenotypes on healthy subjects and suicide attempters (2014) (11)
- Effects of SORL1 gene on Alzheimer's disease. Focus on gender, neuropsychiatric symptoms and pro-inflammatory cytokines. (2013) (11)
- Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: One-month prospective evaluation (2008) (11)
- Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. (2008) (11)
- Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation (2018) (11)
- Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 Variations Does Not Impact Alcohol Dependence Disorder Features (2009) (11)
- Schizophrenia: genetics, prevention and rehabilitation (2008) (11)
- Adenosine Hypothesis of Antipsychotic Drugs Revisited: Pharmacogenomics Variation in Nonacute Schizophrenia. (2016) (11)
- Influence of TAAR6 polymorphisms on response to aripiprazole (2009) (11)
- No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression (2011) (10)
- Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder (2019) (10)
- TPH2 gene variants and anxiety during alcohol detoxification outcome (2009) (10)
- Manifesto for an international digital mental health network (2019) (10)
- Personalized therapies in psychiatry: promises, pitfalls and perspectives (2014) (10)
- Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1 (2019) (10)
- Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients (2014) (10)
- Genetic underpinnings of sociability in the general population (2021) (10)
- Melancholic features in major depression – a European multicenter study (2021) (10)
- Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole (2010) (10)
- Cortico-limbic functional connectivity mediates the effect of early life stress on suicidality in bipolar depressed 5-HTTLPR*s carriers. (2019) (10)
- Genetic variability in tryptophan hydroxylase 2 gene in alcohol dependence and alcohol-related psychopathological symptoms (2015) (10)
- PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study (2016) (10)
- Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder. (2020) (10)
- Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4 (2016) (10)
- Genes involved in neuroplasticity and stressful life events act on the short‐term response to antidepressant treatment: a complex interplay between genetics and environment (2014) (10)
- Paroxetine in the treatment of depressed patients with haematological malignancy: an open‐label study (2004) (10)
- Interleukin-1 alpha and beta, TNF-alpha and HTTLPR gene variants study on alcohol toxicity and detoxification outcome (2006) (10)
- P.1.119 Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism (2003) (9)
- Tyrosine Hydroxylase and DOPA Decarboxylase Gene Variants in Personality Traits (2009) (9)
- Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits (2010) (9)
- Genetics and pharmacogenetics of mood disorders. (2017) (9)
- Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features. (2013) (9)
- A genetic dissection of antipsychotic induced movement disorders. (2013) (9)
- High occupational level is associated with poor response to treatment of depression (2016) (9)
- Generalized tonic-clonic seizure secondary to duloxetine poisoning: a short report with favorable out come. (2012) (9)
- Pharmacogenetics of antidepressants and mood stabilizers. (2012) (9)
- Investigation of epistasis between DAOA and 5HTR1A variants on clinical outcomes in patients with schizophrenia. (2013) (9)
- Clinical and Demographic Predictors of Improvement during Duloxetine Treatment in Patients with Major Depression (2011) (9)
- Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors (2016) (9)
- Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia (2012) (9)
- Temperament and Character Inventory in Bipolar Disorder versus Healthy Controls and Modulatory Effects of 3 Key Functional Gene Variants (2018) (9)
- Pharmacogenetic‐Guided Treatment of Depression: Real‐World Clinical Applications, Challenges, and Perspectives (2021) (9)
- “Separation” of the mother‐child couple: pregnancy and maternity of drug‐dependent women (1994) (9)
- The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries (2022) (8)
- 5-HTTLPR rs25531A > G Differentially Influence Paroxetine and Fluvoxamine Antidepressant Efficacy: A Randomized Controlled Trial. (2012) (8)
- Bipolar disorder: “pure” versus mixed depression over a 1-year follow-up (2012) (8)
- Case–control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder (2012) (8)
- Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia. (2000) (8)
- Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples (2017) (8)
- Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression (2015) (8)
- Mixed, melancholic, and anxious features in depression: a cross-sectional study of sociodemographic and clinical correlates. (2014) (8)
- CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients (2015) (8)
- Personality and Genetics (2007) (8)
- 5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial. (2012) (8)
- Irritable Mood and Subthreshold Hypomanic Episodes Correlate with More Severe Major Depression (2021) (8)
- Role of synaptosome-related (SNARE) genes in adults with attention deficit hyperactivity disorder (2014) (8)
- Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression. (2019) (8)
- Do the estrogen receptors 1 gene variants influence the temperament and character inventory scores in suicidal attempters and healthy subjects? (2009) (8)
- Quantitative neurosymptomatics: Linking quantitative biology to neuropsychiatry (2019) (8)
- Further evidence supporting the association between 5HTR2C gene and bipolar disorder (2010) (8)
- Genomewide interaction and enrichment analysis on antidepressant response (2013) (8)
- The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study (2017) (8)
- Self-esteem in remitted patients with mood disorders is not associated with the dopamine receptor D4 and the serotonin transporter genes (1998) (7)
- Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients (2015) (7)
- Genetic variants associated with psychotic symptoms across psychiatric disorders (2020) (7)
- Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder (2013) (7)
- The black sheep of the family- whole-exome sequencing in family of lithium response discordant bipolar monozygotic twins (2020) (7)
- Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders (2016) (7)
- Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease. (2016) (7)
- Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects (2011) (7)
- The brief assessment of cognition in affective disorders: Normative data for the Italian population. (2019) (7)
- No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample (2010) (7)
- Alzheimer's disease and neurotransmission gene variants: focus on their effects on psychiatric comorbidities and inflammatory parameters (2018) (7)
- The association of childhood trauma, lifetime stressful events and general psychopathological symptoms in euthymic bipolar patients and healthy subjects. (2021) (6)
- DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population (2004) (6)
- Deiodinases, Organic Anion Transporter Polypeptide Polymorphisms, and Thyroid Hormones in Patients with Myocardial Infarction. (2018) (6)
- Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors (2022) (6)
- Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study. (2018) (6)
- Serotonin transporter gene variants and prediction of stress‐induced risk for psychological distress (2011) (6)
- Family history of major depression and residual symptoms in responder and non-responder depressed patients. (2014) (6)
- Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts (2021) (6)
- Excessive daytime sleepiness in depressed women (2010) (6)
- Gene – environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase ( TPH ) , serotonin transporter ( 5-HTTLPR ) and dopamine receptor ( DRD 4 ) gene polymorphisms (6)
- Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in schizophrenia (1999) (6)
- Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial (2015) (6)
- Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly (2019) (6)
- Temperamental and Genetic Predictors of Suicide Attempt and Self-Mutilation (2013) (6)
- S.17.05 Molecular genetics of bipolar disorders: Implication for psychotropic drugs (1997) (6)
- Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression (2020) (6)
- Outcome of affective psychosis (1999) (6)
- Psychological Mechanisms of Mindfulness-Based Interventions (2014) (6)
- Seasonality in Major Depressive Disorder: Effect of Sex and Age. (2021) (6)
- Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia. (2008) (6)
- Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study (2017) (6)
- Genetic Variations within Metalloproteinases Impact on the Prophylaxis of Depressive Phases in Bipolar Patients (2014) (6)
- Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression. (2021) (6)
- Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder (2021) (6)
- No Influence of DTNBP1 Polymorphisms on the Response to Aripiprazole (2010) (5)
- Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review (2022) (5)
- Benefit of slow titration of paroxetine to treat depression in the elderly (2014) (5)
- Analysis of requirements and specifications for a monitoring system to support the self-management of dementia patients at home (2010) (5)
- No influence of FAT polymorphisms in response to aripiprazole (2010) (5)
- Genetic underpinnings of sociability in the UK Biobank (2019) (5)
- Modulation of a number of genes on personality traits in a sample of healthy subjects (2014) (5)
- Opinion paper: poor response to treatment of depression in people in high occupational levels (2018) (5)
- Clozapine augmentation with amisulpride. (2014) (5)
- Factors That Predispose Patients to Treatment-Resistant Depression (2014) (5)
- [5-HT1A gene polymorphisms contributed to antidepressant response in major depression]. (2009) (5)
- DAOA Variants on Diagnosis and Response to Treatment in Patients with Major Depressive Disorder and Bipolar Disorder (2012) (5)
- The 8th Annual Pharmacogenetics in Psychiatry Meeting Report (2009) (5)
- patients with mood disorders (2009) (5)
- Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls. (2017) (5)
- A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response (2021) (5)
- The serotonin transporter and the activity regulated cytoskeleton‐associated protein genes in antidepressant response and resistance: 5‐HTTLPR and other variants (2018) (5)
- Genetics of suicide, from genes to behavior (2010) (5)
- Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder (2008) (5)
- Positive association of DRD4 exon 1 and 3 variants with major psychoses (1996) (4)
- Quetiapine Extended Release: Preliminary Evidence of a Rapid Onset of the Antidepressant Effect in Bipolar Depression (2014) (4)
- The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation? (2022) (4)
- Impact of 5-HTTLPR polymorphism on alexithymia in alcoholic patients after detoxification treatment. (2013) (4)
- Genetics of Mood Disorders (2009) (4)
- Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case–control study (2006) (4)
- Social adjustment among treatment responder patients with mood disorders. (2013) (4)
- Dried Volumetric Microsampling Approaches for the Therapeutic Drug Monitoring of Psychiatric Patients Undergoing Clozapine Treatment (2022) (4)
- Pharmacogenetics of Major Depression: From Research to Clinical Practice (2006) (4)
- Depression, antidepressants, and insulin resistance: which link? (2022) (4)
- Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs (2016) (4)
- DAOA variants and schizophrenia: Influence on diagnosis and treatment outcomes (2011) (4)
- Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease (2019) (4)
- Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence (2021) (4)
- P.2.c.005 Meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder (2008) (4)
- Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role (2018) (4)
- Genetics and drugs. (2007) (4)
- De novo missense variants in LMBRD2 are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features (2020) (3)
- Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients (2021) (3)
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs (2022) (3)
- A model to investigate SNPs’ interaction in GWAS studies (2014) (3)
- P.3.c.055 Clozapine resistance: augmentation strategies (2011) (3)
- Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento Antidepressants and sexual dysfunction: epidemiology, mechanisms and management (2010) (3)
- arison between controlled trials in depression and naturalistic study data (2007) (3)
- Antidepressant induced weight gain (2018) (3)
- PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER (2011) (3)
- Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment (2011) (3)
- Low-dose buprenorphine detoxification in long term methadone addicts (1994) (3)
- The challenge of uncovering the genetics of anxiety (2012) (3)
- A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat (2021) (3)
- The Influence of 5-HTTLPR, BDNF Rs6265 and COMT Rs4680 Polymorphisms on Impulsivity in Bipolar Disorder: The Role of Gender (2022) (3)
- Sulfur Amino Acid Metabolic Process Pathway may Modulate Bipolar Disorder with Alcohol Dependence Comorbidity (2014) (3)
- Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression (2020) (3)
- A molecular pathway analysis of the glutamatergic–monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment (2015) (3)
- ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders (2020) (3)
- Epigenetic basis of psychiatric disorders: a narrative review. (2021) (3)
- Is Pharmacogenetics Useful in Antidepressant Treatment? (2019) (3)
- 6 Signs Your Patient Is at Risk for Treatment-Resistant Depression (2017) (3)
- Potential Benefits of Slow Titration of Paroxetine Treatment in an Elderly Population: Eight-Week Results From a Naturalistic Setting (2013) (3)
- The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression. (2021) (3)
- Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation (2022) (3)
- symptomatology in mood disorders (1998) (3)
- 22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders. (2018) (3)
- Alexithymia, personality and outcome: a naturalistic study in patients with major depression and anxiety disorders (2012) (3)
- Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path. (2022) (2)
- Depressive symptomatology is in fl uenced by chronotypes (2009) (2)
- Thyroid hormone and affective disorders (2009) (2)
- Possible Modulatory Role of ARC Gene Variants in Mood Disorders (2021) (2)
- Antidepressants, present and future (2011) (2)
- Erratum to: HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory (2009) (2)
- P.2.d.042 Predominant polarity in bipolar disorder – is there a genetic base? (2017) (2)
- The XIIth World Congress of Psychiatric Genetics (2005) (2)
- Brexpiprazole: a step forward for precision medicine in resistant depression (2018) (2)
- Pharmacogenomics of psychotropic drugs. (2011) (2)
- The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis (2022) (2)
- The Italian version of the Brief Assessment of Cognition in Affective Disorders: performance of patients with bipolar disorder and healthy controls. (2022) (2)
- Genetics of impulsive-aggressive behavior: ready for application in forensic psychiatry? (2015) (2)
- Association between social adjustment and candidate genes polymorphism in remitted bipolar and unipolar patients (1998) (2)
- The neuropsychological hypothesis of antidepressant drug action revisited. (2015) (2)
- Antidepressants and sexual dysfunction: epidemiology, mechanisms and management (2010) (2)
- Persistent benefits of slow titration of paroxetine in a six‐month follow‐up (2015) (2)
- Multi-omics data integration methods and their applications in psychiatric disorders (2023) (2)
- Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples (2017) (2)
- The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs. (2022) (2)
- Precision medicine in mood disorders (2022) (2)
- The search for personalized antidepressant treatments: what have we learned and where are we going. (2020) (2)
- Antidepressants: Indications, Contraindications, Interactions, and Side Effects (2020) (2)
- Pharmacogenetics of Antidepressant Drugs: An Update (2014) (2)
- Imputed expression of schizophrenia‐associated genes and cognitive measures in patients with schizophrenia (2022) (2)
- Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder (2021) (2)
- Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample (2011) (2)
- P.3.06 A glycogen synthase kinase 3-ß -50 T/CSNP influences long-term response to lithium salts in bipolar illness (2005) (2)
- No influence of SLC6A3 40 base VNTR polymorphism on the response to risperidone (2010) (2)
- Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure: A Case Report. (2020) (2)
- FKBP5 Gene Variants May Modulate Depressive Features in Bipolar Disorder (2019) (2)
- Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study (2022) (2)
- Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features (2022) (2)
- Genetic influence on response to serotonergic antidepressants (2000) (2)
- Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features (2017) (2)
- Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression. (2021) (1)
- Alessitimia, personalità e outcome: uno studio naturalistico in pazienti con depressione maggiore e disturbi d'ansia Alexithymia, personality and outcome: a naturalistic study in patients with major depression and anxiety disorders (2012) (1)
- The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder (2021) (1)
- High occupational level is associated with poor response to the treatment of depression: A replication study (2019) (1)
- P.612 Symptom network structure differences in acute depression between bipolar disorder and major depressive disorder: A network analysis. (2019) (1)
- P.1.a.006 CACNA1C gene and schizophrenia: A case-control and pharmacogenetic study (2015) (1)
- The influence of the serotonin transporter gene 5-HTTLPR polymorphism on suicidal behavior: a meta-analysis (2018) (1)
- Reply to Letter to the Editor "Problems With Ensuring a Double Blind" (2001) (1)
- Genetics of Treatment‐resistant Depression (2013) (1)
- Gene-Environment Interaction Studies in Suicidal Behaviour (2015) (1)
- Pharmacogenomics of Depression (2010) (1)
- Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank. (2021) (1)
- ack of association between the 5 HT receptor polymorphism ( T 102 C ) 2 A and unipolar affective disorder in a multicentric European study (2016) (1)
- Neurobiology of Mood Disorders (2018) (1)
- Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy (2022) (1)
- Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder. (2023) (1)
- Mental fatigue in individuals with psychiatric disorders: a scoping review. (2022) (1)
- The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review (2022) (1)
- Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial (2020) (1)
- Are Noradrenergic Antidepressants a Valuable Choice in the Treatment of Panic Disorder? A Review and Meta Analysis (2009) (1)
- P1.a.013 Effect of HTR7 gene variants on the efficacy of second-generation antipsychotics with 5-HT7R antagonism in Japanese schizophrenia patients (2015) (1)
- Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic–pituitary–adrenal axis, inflammation and autonomous nervous system (2022) (1)
- Alexithymia and personality in patients with anxiety disorders and major depression: effects on treatment outcome (2015) (1)
- Stratification of individuals with lifetime depression and low wellbeing in the UK Biobank. (2022) (1)
- Corrigendum to “DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients” [Neurosci. Lett. 440 (2008) 150–154] (2008) (1)
- Fine-tuning of psychopharmacological treatments. (2022) (1)
- The Use of DNA Microarray in the Pharmacogenetics of Antidepressants: Guidelines for a Targeted Approach (2004) (1)
- Clinical Utility of Fluid Biomarker in Depressive Disorder (2022) (1)
- P03-326 - Treatment-Emergent Sexual Dysfunction Related to Antidepressants: a Meta-Analysis (2010) (1)
- P.2.c.004 Basic fibroblast growth factor (FGF2) gene polymorphisms could contribute to SSRIs treatment response and tolerability (2009) (1)
- Reduced Frontal Cortical Thickness in Generalized Anxiety Disorder (2015) (1)
- P.2.d.031 Predictors for manic switch at depressive episodes in bipolar disorder: the Systematic Treatment Enhancement Program for Bipolar Disorder (2014) (1)
- Demographic and Clinical Features of Mood Disorders. (2004) (1)
- P.2.c.011 Is pharmacogenetic testing ready for antidepressant treatment? A costeffectiveness simulation (2011) (1)
- Difensive styles in female depression (2008) (1)
- Mindfulness-Based Cognitive Therapy vs. Psycho-education for Patients with Anxiety Disorders Who Did Not Achieve Remission Following Adequate Pharmacological Treatment (2021) (1)
- Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder (2022) (1)
- Low-activity alleles of the MAOA gene are associated with measures of hostility. (2015) (1)
- Pharmacogenetics of Antidepressant Drugs (2014) (1)
- The genetics of vascular incidents associated with second-generation antipsychotic administration (2014) (1)
- P.3.013 Genetic variants in ST8SIA2 gene influence treatment outcome in treatment resistant depression: a European multicenter study (2014) (1)
- 57 INVESTIGATING THE COMMON GENETIC BASIS OF ANTIDEPRESSANT RESPONSE (2019) (1)
- Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment (2013) (1)
- Extremely High-Dosage Zolpidem Poisoning With Favorable Outcome. (2021) (1)
- Highlights on Pharmacogenetics and Pharmacogenomics in Depression (2018) (1)
- Epistatic Interactions between CREB and CREM Variants in Affective Disorder (2014) (1)
- Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder (2022) (1)
- Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels: A Case Series. (2021) (1)
- P.2.a.015 Weight gain and antidepressants: a comprehensive review and meta analysis (2008) (1)
- P.6.b.016 Association between CACNA1C gene rs1034936 polymorphism and alcoholism in bipolar disorder (2017) (0)
- P.1.a.021 A molecular pathway analysis of the genes in 22q11.2 provides information on the genetic structure of psychosis (2013) (0)
- Open issues in bipolar and antipsychotic treatments. (2022) (0)
- P.2.f.015 A prospective study of escitalopram in treatment resistant depression not responding to venlafaxine (2013) (0)
- Major depressive disorders: depressive disorders (2006) (0)
- Perspectives for Italian Psychiatry (2009) (0)
- P1.a.023 Impact of a SNP in SIGMAR1 on major depression, bipolar disorder and treatment response (2015) (0)
- P.1.a.002 DTNBP1, HSPs and TAAR6 variations influence schizophrenic phenotype and treatment response (2010) (0)
- P.0882 A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response (2021) (0)
- P.1.a.016 CHL1 gene: a new promising antidepressant response marker in major depression (2013) (0)
- Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant, and Mood-Stabilizing Drugs (2016) (0)
- P.1.g.046 ECG alterations associated with psychotropic drug use in clinical settings: clinical and genetic predictors (2016) (0)
- P.1.001 Genes involved in neuroplasticity and short-term response to antidepressant drugs: a complex interplay between genetics and environment (2014) (0)
- Corrigendum to: “TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study” [Eur Psychiatr 2008;23:390–5] (2009) (0)
- Precision psychiatry (2021) (0)
- Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder (2014) (0)
- M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (2019) (0)
- P.1.a.034 Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease: a systematic review (2015) (0)
- S-49-1 Genetic mechanisms in response to haloperidol and risperidone treatments (1996) (0)
- Contents Vol. 46, 2013 (2013) (0)
- P.3.d.027 Does medication history profile affect treatment response of antagonist and partial agonist at the D2 receptors in schizophrenia? (2014) (0)
- Positive association between bipolar affective disorder and tyrosine hydroxylase gene: 22.2 (1995) (0)
- Polimorfizam gena za serotoninski transporter (5-HTTLPR) i učinkovitost selektivnih inhibitora ponovne pohrane serotonina – imamo li dovoljno dokaza za kliničku praksu (2013) (0)
- Receptors in the Superficial Entorhinal Cortex 1A Serotonin Reduces Polysynaptic Inhibition via 5-HT (2015) (0)
- M44 Investigation of Genetic Variants Within Genes Targets of Antipsychotic Response And Their Signal Cascade In Schizophrenia And Antipsychotic Response (2017) (0)
- Subject Index Vol. 47, 2003 (2003) (0)
- The pharmacogenomics of the serotonin system (2005) (0)
- Examination of potential role of dopaminergic D2, D3 and D4 receptors genes in affective disorders: a european multicentric collaborative study (2000) (0)
- No influence of FAT polymorphisms in response to aripiprazole (2010) (0)
- Erratum to “Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects” [Eur. Neuropsychopharmacol. 19 (2009) 718–725] (2010) (0)
- P.332 Deconstructing major depressive episodes by severity and chronicity: A cross-diagnostic cluster-analysis on a large, international, observational study (2019) (0)
- A European multicenter association study of bipolar and unipolar disorders with dopamine receptor polymorphisms: DRD2, DRD3 and DRD4 (1998) (0)
- SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES (2019) (0)
- Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features (2017) (0)
- P.1.123 CLOCK gene influences insomnia during antidepressant treatment (2003) (0)
- S.03.05 Clinical pharmacogenetic studies in the treatment of depression (2006) (0)
- P.3.c.044 Influence of ANKK1 and DRD2 gene polymorphisms in response to haloperidol (2012) (0)
- Review article Schizophrenia: genetics, prevention and rehabilitation (2009) (0)
- T126. ADVANCING PHARMACOGENOMICS OF ANTICONVULSANT MOOD STABILIZER RESPONSE IN BIPOLAR DISORDER THROUGH THE MOOD STABILIZER GENOMICS (MOSTGEN) CONSORTIUM (2022) (0)
- Defining clinical characteristics of emotion dysregulation in bipolar disorder: A systematic review and meta-analysis (2022) (0)
- T10 Alzheimer’s Disease And Neurotransmission Gene Variants (2017) (0)
- PM449. Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples (2016) (0)
- P.3.d.008 Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials (2017) (0)
- P.179 Polygenic risk scores for multiple psychiatric, inflammatory and cardio-metabolic traits highlight possible genetic overlap with suicide attempt (2020) (0)
- "Pharmacogenetic studies claim that they will change our lives with the promise of individualized therapies; however, initial enthusiasm should be moderated in the light of certain considerations. " (2011) (0)
- P.1.a.012 New insights from cell adhesion molecules in antidepressant action: role of ITGB3 and GAP43 genes (2014) (0)
- P.3.018 Insomnia and somnolence induced by second-generation antidepressants during the treatment of major depression: a meta-analysis (2014) (0)
- Meet the Editorial Board (2015) (0)
- Contents Vol. 62, 2010 (2010) (0)
- 58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA (2019) (0)
- P.2.d.034 How to improve bipolar disorder management? A novel prospective: the use of biomarkers (2015) (0)
- Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation. (2023) (0)
- The XIIth World Congress of Psychiatric Genetics. October 9-13, 2004, Dublin, Ireland. (2005) (0)
- P.2.c.010 The inflammatory genetic background and genetically disruption of lithium related molecular pathways in bipolar disorder patients (2013) (0)
- Familial concordance of SSRIs response as a tool for differentiating mood disorder pedigrees (2000) (0)
- Contents Vol. 56, 2007 (2008) (0)
- SA92THE INFLUENCE OF THE SEROTONIN TRANSPORTER GENE 5-HTTLPR POLYMORPHISM ON SUICIDAL BEHAVIORS: A META-ANALYSIS (2019) (0)
- Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder. (2023) (0)
- SA84 PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE (2019) (0)
- P.057 A genetic predictor of treatment-resistant depression using exome sequencing and genome-wide genotyping (2019) (0)
- P0317 - Serotonin transporter gene and adverse life events in adult ADHD (2008) (0)
- SU85 WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION (2019) (0)
- P.4.021 Genome-wide association analysis and pathway analysis in predicting antidepressant treatment response (2013) (0)
- M34 ECG Alterations Associated with Psychotropic Drug Use In Clinical Settings: Clinical And Genetic Predictors (2017) (0)
- The circadian gene HPER3 and novelty seeking in mood disorders (2005) (0)
- P0308 - Serotonin receptor 1a, 2a, 2c and CONT SNPs and personality traits in suicide attempters and controls (2008) (0)
- Pharmacogenetics and antidepressants (2007) (0)
- S.21.01 Weight gain and antidepressants: a meta-analysis clearly differentiates SSRIs differences (2010) (0)
- P.1.003 Clinical and genetic predictors of worsening after aripiprazole switch: results from a randomised open study (2010) (0)
- P.5.b.002 Association between sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples (2013) (0)
- Age or age of onset: which is the best criterion to classify late-life depression? (2023) (0)
- JS01-02 - Pharmacogenetics in psychiatry: how far from clinical practice? (2011) (0)
- Psychopharmacology: past, present and future. (2022) (0)
- Lack of association between the 5HT 2A receptor polymorphisms ( T102C) and unipolar affective disorder in a multicentic European study (2003) (0)
- W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY (2021) (0)
- Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role (2017) (0)
- Fine-tuning of psychopharmacological treatments. (2022) (0)
- Contents Vol. 47, 2003 (2003) (0)
- P.1.a.022 Role of phospholipases in response to treatment. Data from the STEP-BD study (2013) (0)
- P.1.a.006 Serotonin transporter: an example of gene influence on human behaviour (2008) (0)
- P.0121 Comparing interleukin-1 beta mononuclear lysates and plasma assays in major depression and antidepressant response (2021) (0)
- Genetics of nonpharmacological treatments of depression (2022) (0)
- P.2.b.068 Epidemiology of psychopharmacological options in unipolar major depression in European tertiary psychiatric treatment centers (2016) (0)
- P.2.b.013 Socio-demographic and clinical predictors of antidepressant remission and response in treatment resistant depression (2014) (0)
- GABRA1 receptor polymorphism in bipolar and unipolar affective disorders: a european multicenter association study (1998) (0)
- Clinical predictors of treatment resistant depression: Replication results from the European multicenter study (2018) (0)
- In search of clinical targets for suicide prevention in major depressive disorder. (2023) (0)
- Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study (2022) (0)
- P.3.a.005 A deeper look onto schizophrenia mechanisms. Association with immunological related pathway (2013) (0)
- P.1.05 HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter genetic association study (2004) (0)
- Serotonin receptor 1A and 2C SNPs and personality traits in suicide attempters and controls (2008) (0)
- Dr. Benedetti and Colleagues Reply (2000) (0)
- Interleukin-1 Beta in Peripheral Blood Mononuclear Cell Lysates as a Longitudinal Biomarker of Response to Antidepressants: A Pilot Study (2021) (0)
- The challenge of managing difficult to treat psychiatric conditions. (2023) (0)
- Symptomatologic structure extraction of major psychosis and association with DRD4 exon 1 and 3 variants: 14.2 (1995) (0)
- Psychopathology of dysthymia (1998) (0)
- Advances in the treatment of depression. (2022) (0)
- P.6.f.008 Does genetics predict severity of gambling disorder? A preliminary study on an Italian sample of gamblers (2014) (0)
- Serotonergic drugs as sleep medications (2008) (0)
- P.1.a.007 Four polymorphisms of SLC6A4 are novel predictors of SSRI/SNRI response in depressive disorder: sequencing analysis of SLC6A4 (2015) (0)
- ANTIDEPRESSANTS AND PANIC DISORDER (2012) (0)
- Bipolar disorder and comorbid substance use disorder: a machine-learning approach (2022) (0)
- P.4.011 Clinical features and drug-induced side effects in early versus late antidepressant responders (2013) (0)
- Overcoming Treatment Resistance: Can Pharmacogenetics Help? (2019) (0)
- Authors' reply to “Recommendations for conducting mindfulness based cognitive therapy trials” (2013) (0)
- Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders (2015) (0)
- Genetics of antidepressant response (2010) (0)
- P.1.014 PPP3CC: a new candidate gene in antidepressant response (2014) (0)
- P.2.b.026 Social adjustment among therapy responder patients with mood disorders (2013) (0)
- Genetic polymorphisms influencing response to lithium (2007) (0)
- P.3.026 Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression (2012) (0)
- P.1.a.010 Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder (2017) (0)
- P.2.b.019 The complexity of genetic effects in pharmacogenetics: focus on neuroplasticity, environmental stress and response to antidepressants (2014) (0)
- Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns. (2022) (0)
- Interplay of environmental and clinical factors in psychiatric disorders. (2023) (0)
- PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers (2016) (0)
- 12 GENETIC UNDERPINNINGS OF SOCIABILITY (2019) (0)
- The Role of Pharmacogenetics in Pharmacovigilance of Psychotropic Drugs (2016) (0)
- TH59. INSULINOPATHIES OF THE BRAIN? GENETIC OVERLAP BETWEEN SOMATIC INSULIN-RELATED AND NEUROPSYCHIATRIC DISORDERS (2021) (0)
- S.27.04 Gene-environment interactions in complex psychiatric disorders (1996) (0)
- P.3.003 Pleiotropic genes in psychiatry: calcium channels and the stress-related FKBP5 gene in antidepressant resistance (2018) (0)
- Correction to: Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease (2020) (0)
- P.2.a.028 Gene × environment interaction in depressive disorders: which environment is of risk? (2012) (0)
- Genetics of mood disorders : from pharmacogenetics to disease genetics (2008) (0)
- P.1.a.006 Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples (2016) (0)
- Subject Index Vol. 62, 2010 (2010) (0)
- P.3.c.065 Comparison of multifactor dimensionality reduction (MDR) and neural network analysis: serotonergic system genes and antipsychotic response (2010) (0)
- P.3.015 Socio-demographic and clinical predictors of antidepressant remission and response in treatment resistant depression (2014) (0)
- P.3.b.016 Onset age in schizophrenia spectrum disorders: complex interactions between genetic and environmental factors (2014) (0)
- Corrigendum to ‘Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease’ [J. Neurol. Sci. 370 (November 2016) 162–166] (2017) (0)
- P.1.a.007 A genetic assessment of antipsychotic and antidepressant cardiac iatrogenicity: focus on the proarrhythmic profile (2008) (0)
- Genetic predictors of antidepressant response to total sleep deprivation (2001) (0)
- P.1.24 Serotonin transporter gene and adverse life events in adult ADHD (2008) (0)
- Genetic polymorphisms influencing the response of antidepressants (2012) (0)
- Subject Index Vol. 49, 2004 (2004) (0)
- FC02.03 - Predictors of response to pharmacotherapy in mood and anxiety disorders: Commonalities, differences and indications (2008) (0)
- Front & Back Matter (2013) (0)
- P.335 Drug repositioning for treatment-resistant depression by comparing genetic predictors with known drug targets (2020) (0)
- Pharmacologicaltreatment ofchronicfatiguesyndrome: focusingontheroleof antidepressants (2009) (0)
- nfluence of COX-2 and OXTR polymorphisms on treatment outcome in treatment esistant depression (2012) (0)
- 58-1 Major findings in molecular genetic studies of affective disorders (1997) (0)
- Significant association between the GABA type a receptor alpha 3 gene locus (GABRA3) and affective disorders: A multicentre study (2000) (0)
- Drug repositioning for treatment-resistant depression: insights from a pharmacogenomic study (2020) (0)
- P.2.f.014 PPP3CC gene in antidepressant response: results from three independent samples (2013) (0)
- P.2.e.011 Heat-shock protein-70 genes in bipolar disorder and response to antimanic treatments (2007) (0)
- P.2.d.040 Potential genes behind the difference between bipolar I and bipolar II disorder (2017) (0)
- Pharmacogenetics of antipsychotics: focus on the glutamatergic system (2011) (0)
- Symptomatologic susceptibility genes in major psychoses (2000) (0)
- P.4.01 C-X-C chemokine signalling is implicated in major depressive disorder in a sample of Korean elderly subjects (2019) (0)
- Association analysis of the Tumor necrosis factor gene polymorphisms ( TNFA 238 and 302 ) in the development of schizophrenia : Impact on the antipsychotic treatment response Research Article (2011) (0)
- Single nucleotide polymorphisms (SNPs) implicated in determining predominant polarity in bipolar disorder (2018) (0)
- P.141 Topological data analysis for genetic-driven stratification of patients with major depressive disorder (2020) (0)
- P.0116 Depressive symptoms and personality traits are the main factors associated with wellbeing independent of the diagnosis of depression (2021) (0)
- P.0458 Clinical clusters of acute schizophrenia and their relationship to frontal lobes dysfunction (2021) (0)
- P.2.a.011 Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients (2012) (0)
- 1244 – Bipolar Depression Rating Scale (bdrs): Psychometric Characteristics Of The Italian Validation (2013) (0)
- The time course of second generation antipsychotic metabolic side effects: results from a one-year prospective evaluation in a community mental health service (2007) (0)
- Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study. (2021) (0)
- Subject Index Vol. 56, 2007 (2008) (0)
- P.1.a.015 Brain-Derived Neurotrophic Factor (BDNF) genetic pathway and bipolar disorder (2015) (0)
- P.1.02 Interaction between SERTPR and stressful life events on response to antidepressant treatment (2007) (0)
- Preface (2011) (0)
- Non-Pharmacological Treatment of Affective Disorders (2011) (0)
- P01-68 - Factors Associated to Course of Symptoms in Bipolar Disorder: Acutely Depressed Versus Subthreshold Mixed Patients (2010) (0)
- Erratum to “Pharmacogenetics in major depression: a comprehensive meta-analysis.” [Prog Neuropsychopharmacol Biol Psychiatry 45 (2013) 183–194] (2013) (0)
- Clock genes and mood disorders: Which role? (2011) (0)
- P.2.g.007 Influence of clock gene polymorphism on sleep-wake cycle in depressed bipolar patients: an actigraphic study (2006) (0)
- F105AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION (2019) (0)
- Genetic variants within neuronal cell adhesion genes and antidepressant response in three independent groups (2015) (0)
- Evidence Based Criteria for the Antidepressant Choice (2017) (0)
- No influence of 5-HTTLPR and TPH polymorphisms on illness time course in mood disorders (2000) (0)
- No association between self-esteem and candidate genes polymorphisms in remitted bipolar, unipolar patients and healthy controls (2000) (0)
- F128TRANSDIAGNOSTIC EFFECT ON PSYCHOPATHOLOGY BY PSYCHOSES GENES VARIANTS (2019) (0)
- LOCAL PATTERNS OF SHARED GENETICS AND A GENETIC LATENT FACTOR OF INSULIN RESISTANCE AND NEUROPSYCHIATRIC MULTIMORBIDITY (2022) (0)
- M67 PSYCHIATRIC DISORDERS AND SLC6A4 GENE VARIANTS: POSSIBLE MODULATION OF ALCOHOL DEPENDENCE AND ALZHEIMER'S DISEASE (2019) (0)
- Nonpharmacological treatment of affective disorders. Preface. (2011) (0)
- P.6.b.002 Oxidative stress and expression of alcohol related psychopathological symptoms in alcohol dependent subjects (2014) (0)
- Contents Vol. 68, 2013 (2013) (0)
- P0118 - Pharmacogenetic of DTNBP1 and HSP70 variations in the bipolar acute treatment with mood stabilizers (2008) (0)
- GABRA1 as a possible candidate gene for bipolar disorder (1996) (0)
- White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress (2018) (0)
- S.3.2 Genetic predictors of illness and treatment response (2007) (0)
- P.1.005 Glutamatergic gene variants impact the side effects and antipsychotic efficacy of haloperidol (2010) (0)
- W68. A META-ANALYSIS OF POLYGENIC RISK SCORES FOR MOOD DISORDERS, NEUROTICISM, AND SCHIZOPHRENIA IN ANTIDEPRESSANT RESPONSE (2021) (0)
- P.2.f.025 Specificity profile of venlafaxine and sertraline in major depression: meta-regression of double-blind, randomized clinical trials (2013) (0)
- Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis (2015) (0)
- P.3.f.021 Genetic variants within key nodes of the cascade of antipsychotic mechanisms: effects on treatment response and schizophrenia psychopathology (2017) (0)
- P.021 Social dysfunction in mood disorders and schizophrenia: clinical correlates in four independent samples (2019) (0)
- Genetic predictors of treatment response in mood disorders (2000) (0)
- P.2.f.006 Temperament and character inventory and response to antidepressant treatment (2015) (0)
- on clinical outcomes in patients with major depressive disorder (2013) (0)
- A genome-wide association study of treatment-resistant depression and meta-analysis with STAR*D (2018) (0)
- P.0362 Transcriptome-wide association study of treatment-resistant depression for drug repurposing (2021) (0)
- A european multicenter association study with 5-HT2A receptor polymorphism in unipolar and bipolar affective disorders (1998) (0)
- Differences in TP 53 and APC gene polymorphisms between Korean schizophrenia and colon cancer patients (1980) (0)
- S.25.03 Pharmacogenetics of efficacy and treatment side effects in bipolar disorder (2013) (0)
- P.2.d.048 COMT modulates working memory and impulsivity control in bipolar disorder (2014) (0)
- PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH (2022) (0)
- E.02.02 Pitfalls, problems and future (2011) (0)
- P.2.f.024 High occupational level is associated with poor response to treatment of depression (2016) (0)
- Contents Vol. 49, 2004 (2004) (0)
- P.3.d.026 Pharmacogenetics of clozapine response and metabolic side effects: a comprehensive review and meta-analysis (2014) (0)
- Psychomotor agitation in bipolar I and unipolar depression. Clinical correlates and outcome (2007) (0)
- Age as a moderating factor of treatment resistance in depression. (2023) (0)
- P.2.e.025 Bipolar depression: quetiapine extended release effectiveness (2011) (0)
- Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders (2017) (0)
- S.02.05 European research programme on treatment resistant depression (2007) (0)
- METHODS FOR OBTAINING CLINICALLY USEFUL PHARMACOGENETIC PREDICTORS; AN EXAMPLE OF A DETAILED INVESTIGATION IN AN HALOPERIDOL TREATED SAMPLE (2010) (0)
- Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideation (2021) (0)
- PATHOPHYSIOLOGY OF MOOD DISORDERS: PHARMACOGENETIC ASPECTS (2013) (0)
- Is long-acting injectable aripiprazole useful for the treatment of acute exacerbation of schizophrenia? (2016) (0)
- PS87. An update on prediction of treatment outcome in treatment resistant depression (2016) (0)
- P.1.a.002 Genetics of long-term treatment outcome in bipolar disorder (2015) (0)
- P.3.021 Potential benefits of slow titration of paroxetine treatment in elderly population: 6-month results from a naturalistic setting (2012) (0)
- Characterization of medication side effects in patients with mostly resistant depression in a real-world setting. (2022) (0)
- P.2.b.026 The relation between major depressive disorder and comorbid generalized anxiety disorder – results from a European multicenter, cross-sectional survey (2017) (0)
- Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease (2019) (0)
- Strategies for improving schizophrenia treatment. (2022) (0)
- P.306 Reduced chemokine ligand 1/GRO chemokine plasma levels are a possible biomarker of elderly depression (2019) (0)
- Contents Vol. 71, 2015 (2015) (0)
- Reply to Comments by Dr Rico-villademoros (2007) (0)
- P.1.115 CLOCK gene and circadian mood fluctuations in bipolar depression (2003) (0)
- P.1.a.009 Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls (2016) (0)
- Association between schizophrenia and DRD3 in a large Italian population (1996) (0)
- P.3.b.007 Epistasis between variations located in TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotics (2010) (0)
- Attrition in treatment-resistant depression: predictors and clinical impact. (2019) (0)
- P.2.a.029 The role of serotonergic genes and environmental stress on the development of depressive symptoms and neuroticism (2012) (0)
- P.321 Clinical parameters associated with augmentation and combination treatment in unipolar depression (2019) (0)
- P.2.c.026 Rapid versus slow titration of paroxetine antidepressant treatment in elderly population: an observational study (2011) (0)
- 5-HT2A RS643627 and RS594242 polymorphisms and personality traits (2006) (0)
- CONFERENCIA MAGISTRAL PHARMACOGENETICS OF ANTIDEPRESSANTS (2003) (0)
- Sleep and Mental Illness: Effects of antidepressants on gene expression (2010) (0)
- P.3.d.022 Pharmacological treatment of acute agitation in schizophrenia (2013) (0)
- Highlights from the latest articles in suicide research. (2014) (0)
- P0208 - HTR1A polymorphisms are associated with the antidepressant response in patients with major depressive disorder (2008) (0)
- Suicidal behaviour: genes, environmental stress and temperamental traits (2015) (0)
- Prescribing patterns of psychiatric drugs in major depressive disorder – Findings from a large European multicenter, cross-sectional study (2017) (0)
- Possible biomarkers modulating haloperidol efficacy and/or tolerability. (2016) (0)
- Erratum to: Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder (2013) (0)
- Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression (2012) (0)
- P.2.b.035 The combined effect of genetic polymorphisms and clinical parameters on treatment response and resistance in major depressive disorder (2014) (0)
- A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder (2018) (0)
- Social withdrawal and neurocognitive correlates in schizophrenia (2021) (0)
- Correction to: Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease (2020) (0)
- Clinical predictors of antidepressant response and remission in treatment resistant depression (2007) (0)
- In fl uence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia (2011) (0)
- P.1.025 Fluvoxamine response in nondemented elderly compared to younger depressives (2003) (0)
- P.0174 Imputed gene expression scores and cognitive function in patients with schizophrenia (2021) (0)
- SU99 EXPLORATORY FINDINGS MAY IMPLICATE GENE'S VARIANTS, RELATED TO ANTIPSYCHOTIC MECHANISMS OF ACTION, WITH SCHIZOPHRENIA PSYCHOPATHOLOGICAL FEATURES (2019) (0)
- SU110 ROLE OF 108 SCHIZOPHRENIA-ASSOCIATED LOCI IN MODULATING PSYCHOPATOLOGICAL DIMENSIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER (2017) (0)
- Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278] (2013) (0)
- P.171 Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder (2020) (0)
- P.2.f.011 Socio-demographic and clinical predictors of non response/non remission in treatment resistant depressed patients: a systematic review (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alessandro Serretti?
Alessandro Serretti is affiliated with the following schools:
